期刊文献+

糖皮质激素治疗重症肺炎支原体肺炎的临床疗效观察 被引量:7

Observation on Clinical Effect of Glucocorticoid Treatment of Severe Mycoplasma Pneumonia
下载PDF
导出
摘要 目的分析探讨应用糖皮质激素治疗重症支原体肺炎的临床效果。方法选择我院2014年1~12月收治的84例重症支原体肺炎患者作为观察对象,采用随机的方式将其分为观察组和对照组各42例。对照组患者应用阿奇霉素进行治疗;观察组在此基础上加用糖皮质激素。分析对比两组临床治疗效果。结果观察组患者的临床总有效率高于对照组,且临床症状改善时间优于对照组,差异具有统计学意义(P〈0.05)。结论对重症支原体肺炎患者应用糖皮质激素治疗能够快速改善患者临床症状、提高治疗有效率。 Objective To analyze application of glucocorticoid treatment the clinical effect of severe mycoplasma pneumonia. Methods Our hospital between January 2014 ~ December 2014 treated 84 cases of severe mycoplasma pneumonia patients as research object,uses the random,it can be divided into observation group and control group(n=42). Control group patients used azithromycin treatment. Observation group based on the combined with glucocorticoid. Contrast analysis of two groups of clinical therapeutic effect. Results The observation group of patients with clinical total effective rate was significantly higher than that of control group,and clinical symptoms improved time is better than that of control group,the difference statistically significant(P〈0.05). Conclusion In patients with severe mycoplasma pneumonia patients with glucocorticoid treatment can quickly improve clinical symptoms,improve the treatment efficiency.
作者 张振国
出处 《继续医学教育》 2015年第10期159-160,共2页 Continuing Medical Education
关键词 支原体肺炎 糖皮质激素 阿奇霉素 临床效果 Mycoplasma pneumonia Glucocorticoids Azithromycin Clinical effect
  • 相关文献

参考文献5

二级参考文献43

  • 1韩晓华,刘立云,敬宏,刘铁英,赵永强,尚云晓.小儿肺炎支原体肺炎合并全身炎症反应综合征时炎性相关因素的变化及临床意义[J].中国当代儿科杂志,2007,9(4):347-350. 被引量:42
  • 2Principi N,Esposito S,Blasi F,et al.Role of mycoplasmapneumoniae and chlamydia pneumoniae in children withcommunity-acquired lower respiratory tract infections[J].Clin Infect Dis,2001,32(9):1281. 被引量:1
  • 3Rasmussen JN,Voldstedlund M,Andersen RL,et al.Increased incidence of mycoplasma pneumoniae infectionsdetected by laboratory-based surveillance in Denmark in2010[J].Euro Surveill,2010,15(45):19708. 被引量:1
  • 4Shibli F,Chazan B,Nitzan O,et al.Etiology ofcommunity-acquired pneumonia in hospitalized patients innorthern Israel[J].Isr Med Assoc J.2010,12(8):477-482. 被引量:1
  • 5Tanaka H,Narita M,Teramoto S,et al.Role ofinterleukin-18 and T-helper type 1 cytokines in thedevelopment of mycoplasma pneumoniae pneumonia inadults[J].Chest,2002,121(5):1493-1497. 被引量:1
  • 6Tagliabue C,Salvatore CM,Techasaensiri C,et al.Theimpact of steroids given with macrolide therapy onexperimental Mycoplasma pneumoniae respiratoryinfection[J].J Infect Dis,2008,198(8):1180-1188. 被引量:1
  • 7Radisic M,Torn A,Gutierrez P,et al.Severe acute lunginjury caused by mycoplasma pneumoniae:potential rolefor steroid pulses in treatment[J].Clin Infect Dis,2000,31(6):1507-1511. 被引量:1
  • 8Lee KY,Lee HS,Hong JH,et al.Role of prednisolonetreatment in severe mycoplasma pneumoniae pneumonia inchildren[J].Pediatr Pulmonol,2006,41(3):263-268. 被引量:1
  • 9Tamura A,Matsubara K,Tanaka T,et al.Methyl-prednisolone pulse therapy for refractory mycoplasmapneumoniae pneumonia in children[J].J Infect,2008,57(3):223-228. 被引量:1
  • 10Chu HW,Campbell JA,Rino JG,et al.Inhaled fluticasonepropionate reduces concentration of mycoplasmapneumoniae,inflammation,and bronchial hyperres-ponsiveness in lungs of mice[J].J Infect Dis,2004,189(15):1119-1127. 被引量:1

共引文献59

同被引文献47

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部